comparemela.com

Latest Breaking News On - Adhera therapeutics inc - Page 6 : comparemela.com

Adhera Therapeutics Appoints Trond K Waerness to Board of Directors

Adhera Therapeutics Appoints Trond K. Waerness to Board of Directors April 23, 2021 09:00 ET | Source: Adhera Therapeutics, Inc. Adhera Therapeutics, Inc. City of Industry, UNITED STATES Baton Rouge, LA, April 23, 2021 (GLOBE NEWSWIRE) Adhera Therapeutics, Inc. (OTCPK: ATRX) ( Adhera Therapeutics or the Company ), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, is pleased to announce the appointment of Trond K. Waerness to the Company’s Board of Directors. Mr. Waerness, age 53, a pharmaceutical executive who has worked in the industry since 1998, with experience in all aspects of pharmaceutical commercialization. Companies include Glaxo-Wellcome, Novartis, Cornerstone Biopharma, Jobson Healthcare, Rx Sample Solutions, and MedVantx. He has held roles in sales, sales management, BD, M&A, operations, and marketing on both the manufacturer an

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.